Roxana Baluna

826 total citations
17 papers, 622 citations indexed

About

Roxana Baluna is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Roxana Baluna has authored 17 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Otorhinolaryngology and 5 papers in Oncology. Recurrent topics in Roxana Baluna's work include Head and Neck Cancer Studies (5 papers), Cancer Diagnosis and Treatment (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Roxana Baluna is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Cancer Diagnosis and Treatment (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Roxana Baluna collaborates with scholars based in United States and Romania. Roxana Baluna's co-authors include Ellen S. Vitetta, Victor Gheţie, Josep Rizo, Brian Gordon, Tony Y. Eng, Charles R. Thomas, Yong Huang, Federico L. Ampil, Ghali E. Ghali and Gloria Caldito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Radiation Oncology*Biology*Physics and Experimental Cell Research.

In The Last Decade

Roxana Baluna

16 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxana Baluna United States 10 395 169 169 158 113 17 622
Jason M. Redman United States 16 583 1.5× 284 1.7× 38 0.2× 571 3.6× 117 1.0× 53 1.0k
J. C. Laurent France 10 176 0.4× 189 1.1× 103 0.6× 94 0.6× 59 0.5× 14 479
M. G. Rosenblum United States 13 251 0.6× 171 1.0× 98 0.6× 134 0.8× 208 1.8× 26 575
Herbert R. Lamche Austria 9 163 0.4× 194 1.1× 23 0.1× 249 1.6× 71 0.6× 18 542
Muneo Miyama-Inaba Japan 11 475 1.2× 202 1.2× 107 0.6× 54 0.3× 216 1.9× 19 712
Avi Eisenthal Israel 17 558 1.4× 237 1.4× 45 0.3× 241 1.5× 138 1.2× 53 846
Hiromoto Mizoguchi Japan 7 517 1.3× 163 1.0× 24 0.1× 271 1.7× 62 0.5× 7 748
Danielle M. Lussier United States 6 518 1.3× 274 1.6× 36 0.2× 534 3.4× 24 0.2× 8 990
Z. Mark United States 7 253 0.6× 378 2.2× 26 0.2× 103 0.7× 33 0.3× 9 816
Gary A. Truitt United States 9 422 1.1× 385 2.3× 61 0.4× 416 2.6× 69 0.6× 15 961

Countries citing papers authored by Roxana Baluna

Since Specialization
Citations

This map shows the geographic impact of Roxana Baluna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Baluna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Baluna more than expected).

Fields of papers citing papers by Roxana Baluna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Baluna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Baluna. The network helps show where Roxana Baluna may publish in the future.

Co-authorship network of co-authors of Roxana Baluna

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Baluna. A scholar is included among the top collaborators of Roxana Baluna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Baluna. Roxana Baluna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ampil, Federico L., et al.. (2014). Postoperative Management in Laryngeal Cancer with Subglottic Extension and Histologically Negative Nodes: Which Patients Need Adjuvant Radiotherapy?. Ear Nose & Throat Journal. 93(8). 354–360. 2 indexed citations
2.
Ampil, Federico L., et al.. (2011). How Intensive Should Radiotherapy for Head and Neck Cancer With Synchronous Distant Metastases Be? Review of Cases. Journal of Oral and Maxillofacial Surgery. 70(3). 730–733. 12 indexed citations
3.
Ampil, Federico L., Gloria Caldito, Joel Thibodeaux, Guillermo Sangster, & Roxana Baluna. (2010). Radiotherapy for cervical spine metastases in breast cancer patients. European Journal of Orthopaedic Surgery & Traumatology. 20(7). 527–531.
4.
Ampil, Federico L., et al.. (2009). Post-laryngectomy stomal cancer recurrences, re-treatment decisions and outcomes: Case series. Journal of Cranio-Maxillofacial Surgery. 37(6). 349–351. 7 indexed citations
5.
Ampil, Federico L., Roxana Baluna, Gary V. Burton, & Anil Nanda. (2009). Paraplegia of spinal epidural compression by metastatic breast cancer and urgent radiotherapy—timeliness for naught?. Journal of Neuro-Oncology. 95(1). 101–103. 1 indexed citations
6.
Ampil, Federico L., Gloria Caldito, Ghali E. Ghali, & Roxana Baluna. (2009). Does the Negative Node Count Affect Disease-Free Survival in Early-Stage Oral Cavity Cancer?. Journal of Oral and Maxillofacial Surgery. 67(11). 2473–2475. 15 indexed citations
7.
Baluna, Roxana, Tony Y. Eng, & Charles R. Thomas. (2006). Adhesion Molecules in Radiotherapy. Radiation Research. 166(6). 819–831. 56 indexed citations
8.
Baluna, Roxana, Clifton D. Fuller, Tony Y. Eng, & Charles R. Thomas. (2004). Plasma fibronectin levels in cancer patients undergoing radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 60(1). S375–S376. 1 indexed citations
9.
Baluna, Roxana, et al.. (2004). Plasma fibronectin levels in cancer patients undergoing radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 60. S375–S376. 1 indexed citations
10.
Baluna, Roxana, et al.. (2000). The Effect of a Monoclonal Antibody Coupled to Ricin A Chain-Derived Peptides on Endothelial Cells in Vitro: Insights into Toxin-Mediated Vascular Damage. Experimental Cell Research. 258(2). 417–424. 56 indexed citations
11.
Baluna, Roxana & Ellen S. Vitetta. (1999). An In Vivo Model to Study Immunotoxin-Induced Vascular Leak in Human Tissue. Journal of Immunotherapy. 22(1). 41–47. 27 indexed citations
12.
Baluna, Roxana, Josep Rizo, Brian Gordon, Victor Gheţie, & Ellen S. Vitetta. (1999). Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proceedings of the National Academy of Sciences. 96(7). 3957–3962. 151 indexed citations
13.
Baluna, Roxana & Ellen S. Vitetta. (1997). Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology. 37(2-3). 117–132. 209 indexed citations
14.
Huang, Yong, Roxana Baluna, & Ellen S. Vitetta. (1997). Adhesion molecules as targets for cancer therapy.. PubMed. 12(2). 467–77. 41 indexed citations
15.
Baluna, Roxana, E. A. Sausville, Marvin J. Stone, et al.. (1996). Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins.. PubMed. 2(10). 1705–12. 18 indexed citations
16.
Baluna, Roxana, Victor Gheţie, Nancy Oppenheimer‐Marks, & Ellen S. Vitetta. (1996). Fibronectin inhibits the cytotoxic effect of ricin A chain on endothelial cells. International Journal of Immunopharmacology. 18(6-7). 355–361. 22 indexed citations
17.
Popescu, Dan M., et al.. (1989). Plasma fibronectin level in patients with connective tissue diseases.. PubMed. 26(4). 267–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026